Cellugenix Peptides

Retatrutide 10mg is sold as “GLP 3 (R) 10mg,” SKU 20-1, at $99.99 for one vial, on the product page at /product/glp-3-10mg/, read today; no tiered or multi-vial pricing appears on that page, only a quantity selector. A marquee banner repeated on every page fetched states the rebrand plainly, reading, after a Note: prefix, that Retatrutide is now available as GLP-3; in the source markup both compound names are set in stylized Unicode mathematical bold glyphs rather than plain letters, so a text search, a screen reader, or automated scanning for the ordinary compound name will not match the banner. The product page’s own specification block lists purity by HPLC at or above 99 percent, net content 10 mg, and storage at 2 to 8 degrees Celsius, and its “View COA” control routes not to a document for this SKU but to the general /coas/ library page. That library is built from a client-side array named cgxCoas embedded directly in the page markup rather than loaded from any API, so it is readable from the raw HTML with no script execution needed; it holds 28 entries against 65 product URLs in the live product-sitemap. One of the 28 is named “GLP3 10mg,” carrying a bare purity field of 99.97 with no percent sign and no method attached in the array itself (units and method appear only on the certificate image the entry links to), and that image’s filename still carries the lab’s internal code for the original document, TestReport_CP-RETA-10-122925.pdf, so the code RETA-10 for retatrutide 10mg survives into the published filename even though the product is marketed only as GLP-3 on every customer-facing page. I opened that image in full. It is a Certificate of Analysis from a lab styled Testides, report number CP-RETA-10-122925, generated January 8, 2026, naming the peptide as Retatrutide, client Cellugenix, lot L25-01, appearance a white lyophilized powder. Four figures are printed: purity of 99.97 percent by the method the certificate’s own Analysis block names, HPLC-UV; total content 10.62 mg against an expected content of 10 mg, for a fill accuracy of 106.2 percent. The certificate’s Timeline block leaves two of four fields blank, Requested and Reported both read N/A, and the Analysis block’s Customer field reads the single word “admin” rather than any buyer or order reference. The visual-documentation panel beneath the four figures is captioned “HPLC-MS Chromatogram,” naming a mass-spectrometry technique the Analysis block itself does not list as the method used, so the document names one method in its data table and a different one in its own chromatogram caption; the chromatogram itself shows a single retention-time peak with no separate mass-spectrum trace or observed-versus-theoretical mass figure anywhere on the page.

The site’s own Quality Standards & Testing page, read in full today, sets out a five-part testing sequence it says every batch receives before release: purity by reversed-phase HPLC, identity confirmed by mass spectrometry comparing observed mass to theoretical mass, an endotoxin quantification assay, a residual-solvent screen, and an appearance and solubility check, and it states a COA should also carry molecular formula, molecular weight, and production and expiry dates. The retatrutide 10mg certificate actually published carries none of that: no molecular formula or weight, no endotoxin figure, no residual-solvent figure, and no separate mass-spectrum output despite the mass-spectrometry caption on its chromatogram; the document holds only purity, total content, expected content, and fill accuracy, four of the roughly nine data points the policy page describes as standard. Coverage is a second, separate gap: the embedded cgxCoas array holds 28 named entries, all peptide, blend, or nootropic products, against 65 product URLs in the live product-sitemap, so under half the catalog carries any published certificate. The /coas/ page itself, before any client-side script runs, serves a filter interface whose markup already contains an empty-state message stating that no matches were found for the current filter, so a plain fetch of that page shows an apparently empty library even though the certificate data is sitting in the same page’s own source, one script tag down.

On the laboratory named on every certificate. testides.com resolves, but the four page paths requested today, the homepage, /about, /verify, and /contact, each returned a structurally identical 975-byte shell of a single-page application titled “Testides - Client Portal,” alike in every byte except a per-request Cloudflare challenge token, sitting behind a Cloudflare bot-management script that has to run in a browser before any content would render; /robots.txt instead returned a populated robots.txt, a Content-Signal policy block plus per-agent disallow rules for named AI crawlers, with a shorter, structurally different HTML fragment appended. No street address, telephone number, accreditation statement, or description of the lab’s own operation is reachable by a direct fetch of that domain. The only descriptive language for this lab anywhere in this dossier’s sources is the tagline printed on the Cellugenix product pages and on the certificate image itself, styling Testides as “North America’s Leading Peptide Testing Laboratory,” a claim the lab’s own reachable pages neither confirm nor deny, since they carry no public content of any kind.

Jurisdiction. No page fetched publishes a street address, a company registration number, or a stated incorporation jurisdiction for Cellugenix Peptides under any name; the Contact page gives only a business name and an email address. The strongest signals available point to Canada. The Privacy Policy states it is written for compliance with PIPEDA and provincial Canadian privacy law, grants Canadian residents specifically the right to complain to the Office of the Privacy Commissioner of Canada, and lists a contact phone number, 1-403-952-9999, whose area code, 403, covers Calgary, Alberta. That same Privacy Policy names the site as https://cellugenixpeptides.com, a .com the live storefront does not use (it runs on .io), and lists Shopify as “our eCommerce platform provider,” even though every page fetched carries WordPress and WooCommerce markers, wp-content paths, a wp-json REST index, and Yoast SEO meta tags, so the policy text reads as reused boilerplate that was never updated for this storefront’s actual domain or platform. Every page fetched, including the page addressed to United States buyers, carries an identical footer block titled “Legal Notice (Canada)” naming Health Canada as the only regulator referenced anywhere fetched; the separate Refund and Return Policy carries that same footer block, contains no governing-law or jurisdiction clause of its own, and names no United States regulator, and neither does any other page fetched, including the page addressed to United States buyers. The Shipping & International Ordering Guide places its Canada section under the heading Domestic Shipping and opens the United States section with the sentence “The same process applies domestically in the U.S.,” using Canada as the base case that the U.S. section is written against. None of this is a registration record on its own, but the accumulated pattern, phone prefix, privacy statute, a Canada-only legal footer repeated on the USA-facing pages, and a shipping page structured around Canada as the domestic case, reads as a Canada-based operation marketing outward to USA, Canada, and International buyers as three storefront sections rather than as a company whose home jurisdiction is the USA. Five testimonials on the homepage are attributed to named individuals with lab titles; two of the five surnames, Gagnon and Tremblay, are common French-Canadian surnames, which proves nothing on its own but sits alongside the rest of the pattern.

A banner repeated on every page fetched reads: “New! Secure Credit Card Payments are now available through our trusted payment partner, VPPass.” The banner is not a working hyperlink; its anchor tag carries an empty href, so the site itself does not point to any specific domain for VPPass, and the checkout page redirects without an item already in the cart, which this dossier does not place. Searching for the name independently, vppass.com resolves to a live site, but it describes a consumer NFT membership product, a loyalty pass minted on the Polygon blockchain and priced from 5 to 5,000 US dollars, offering loyalty points, a prepaid card, and, at its higher tiers, an IBAN account described on the page itself as subject to jurisdiction and KYC review. Nothing on that page describes merchant credit-card processing of the kind the Cellugenix banner claims to offer. Whether this is the same VPPass the banner refers to is not established either way by anything fetched here; it is recorded as an open question, not a finding.